Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H von der Leyen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Klinische Wochenschrift|June 15, 1989
Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failureH von der Leyen
Zeitschrift Fur Kardiologie|October 1, 1993
[Multivariate analysis of prognostically significant parameters in acute transmural myocardial infarct]I Spyridopoulos, H von der Leyen, P R Lichtlen
Pharmacological Research|July 1, 1989
New positive inotropic agents acting by phosphodiesterase inhibition or alpha 1-adrenergic stimulationH von der Leyen, W Schmitz, H Scholz, et al.
Journal of Cardiovascular Pharmacology|March 1, 1992
Comparison of enoximone and piroximone in patients after mitral valve operation: a prospective and controlled clinical studyB Hausen, B Heublein, J Vogelpohl, et al.
Der Internist|September 8, 2020
[Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy]J Beige, J Drube, H von der Leyen, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Phosphodiesterase inhibition and positive inotropic effectsW Schmitz, H von der Leyen, W Meyer, et al.
Arzneimittel-Forschung|September 1, 1988
Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardiumD Brunkhorst, H von der Leyen, W Meyer, et al.
European Heart Journal|May 1, 1992
Enoximone, a post-operative inodilator in patients following mitral valve operation: a prospective and controlled studyB Hausen, H von der Leyen, J Vogelpohl, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1988
Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig heartsT Bethke, D Brunkhorst, H von der Leyen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1989
Effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly selective adenosine receptor antagonist, on force of contraction in guinea-pig atrial and ventricular cardiac preparationsH von der Leyen, W Schmitz, H Scholz, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Klinische Wochenschrift|June 15, 1989
Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failureH von der Leyen
Zeitschrift Fur Kardiologie|October 1, 1993
[Multivariate analysis of prognostically significant parameters in acute transmural myocardial infarct]I Spyridopoulos, H von der Leyen, P R Lichtlen
Pharmacological Research|July 1, 1989
New positive inotropic agents acting by phosphodiesterase inhibition or alpha 1-adrenergic stimulationH von der Leyen, W Schmitz, H Scholz, et al.
Journal of Cardiovascular Pharmacology|March 1, 1992
Comparison of enoximone and piroximone in patients after mitral valve operation: a prospective and controlled clinical studyB Hausen, B Heublein, J Vogelpohl, et al.
Der Internist|September 8, 2020
[Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy]J Beige, J Drube, H von der Leyen, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Phosphodiesterase inhibition and positive inotropic effectsW Schmitz, H von der Leyen, W Meyer, et al.
Arzneimittel-Forschung|September 1, 1988
Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardiumD Brunkhorst, H von der Leyen, W Meyer, et al.
European Heart Journal|May 1, 1992
Enoximone, a post-operative inodilator in patients following mitral valve operation: a prospective and controlled studyB Hausen, H von der Leyen, J Vogelpohl, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1988
Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig heartsT Bethke, D Brunkhorst, H von der Leyen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1989
Effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly selective adenosine receptor antagonist, on force of contraction in guinea-pig atrial and ventricular cardiac preparationsH von der Leyen, W Schmitz, H Scholz, et al.
Pageof 3